This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rui, L.
Right arrow Articles by Carter-Su, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rui, L.
Right arrow Articles by Carter-Su, C.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, May 2000, p. 3168-3177, Vol. 20, No. 9
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Differential Binding to and Regulation of JAK2 by the SH2 Domain and N-Terminal Region of SH2-Bbeta

Liangyou Rui, David R. Gunter, James Herrington, and Christin Carter-Su*

Department of Physiology, University of Michigan Medical School, Ann Arbor, Michigan 48109-0622

Received 7 July 1999/Returned for modification 10 October 1999/Accepted 31 January 2000

SH2-Bbeta has been shown to bind via its SH2 (Src homology 2) domain to tyrosyl-phosphorylated JAK2 and strongly activate JAK2. In this study, we demonstrate the existence of an additional binding site(s) for JAK2 within the N-terminal region of SH2-Bbeta (amino acids 1 to 555) and the ability of this region of SH2-B to inhibit JAK2. Four lines of evidence support the existence of this additional binding site(s). In a glutathione S-transferase pull-down assay, wild-type SH2-Bbeta and SH2-Bbeta (R555E) with a defective SH2 domain bind to both tyrosyl-phosphorylated JAK2 from growth hormone (GH)-treated cells and non-tyrosyl-phosphorylated JAK2 from control cells, whereas the SH2 domain of SH2-Bbeta binds only to tyrosyl-phosphorylated JAK2 from GH-treated cells. Similarly, JAK2 is present in alpha SH2-B immunoprecipitates in the absence and presence of GH, with GH substantially increasing the coprecipitation of JAK2 with SH2-B. When coexpressed in COS cells, SH2-Bbeta coimmunoprecipitates not only wild-type, tyrosyl-phosphorylated JAK2 but also kinase-inactive, non-tyrosyl-phosphorylated JAK2(K882E), although to a lesser extent. Delta C555 (amino acids 1 to 555 of SH2-Bbeta ) that lacks most of the SH2 domain binds similarly to wild-type JAK2 and kinase-inactive JAK2(K882E). Experiments using a series of N- and C-terminally truncated SH2-Bbeta constructs indicate that the pleckstrin homology (PH) domain (amino acids 269 to 410) and amino acids 410 to 555 are necessary for maximal binding of SH2-Bbeta to inactive JAK2, but neither region alone is sufficient for maximal binding. The SH2 domain of SH2-Bbeta is necessary and sufficient for the stimulatory effect of SH2-Bbeta on JAK2 and JAK2-mediated tyrosyl phosphorylation of Stat5B. In contrast, Delta C555 lacking the SH2 domain, and to a lesser extent the PH domain alone, inhibits JAK2. Delta C555 also blocks JAK2-mediated tyrosyl phosphorylation of Stat5B in COS cells and GH-stimulated nuclear accumulation of Stat5B in 3T3-F442A cells. These data indicate that in addition to the SH2 domain, SH2-Bbeta has one or more lower-affinity binding sites for JAK2 within amino acids 269 to 555. The interaction via this site(s) in SH2-B with inactive JAK2 seems likely to increase the local concentration of SH2-Bbeta around JAK2, thereby facilitating binding of the SH2 domain to ligand-activated JAK2. This would result in a more rapid and robust cellular response to hormones and cytokines that activate JAK2. This interaction between inactive JAK2 and SH2-B may also help prevent abnormal activation of JAK2.


* Corresponding author. Mailing address: Department of Physiology, The University of Michigan Medical School, Ann Arbor, MI 48109-0622. Phone: (734) 763-2561. Fax: (734) 647-9523. E-mail: cartersu{at}umich.edu.


Molecular and Cellular Biology, May 2000, p. 3168-3177, Vol. 20, No. 9
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Rider, L., Tao, J., Snyder, S., Brinley, B., Lu, J., Diakonova, M. (2009). Adapter Protein SH2B1{beta} Cross-Links Actin Filaments and Regulates Actin Cytoskeleton. Mol. Endocrinol. 23: 1065-1076 [Abstract] [Full Text]  
  • Gery, S., Cao, Q., Gueller, S., Xing, H., Tefferi, A., Koeffler, H. P. (2009). Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F. J. Leukoc. Biol. 85: 957-965 [Abstract] [Full Text]  
  • Rider, L., Shatrova, A., Feener, E. P., Webb, L., Diakonova, M. (2007). JAK2 Tyrosine Kinase Phosphorylates PAK1 and Regulates PAK1 Activity and Functions. J. Biol. Chem. 282: 30985-30996 [Abstract] [Full Text]  
  • Li, Z., Zhou, Y., Carter-Su, C., Myers, M. G. Jr., Rui, L. (2007). SH2B1 Enhances Leptin Signaling by Both Janus Kinase 2 Tyr813 Phosphorylation-Dependent and -Independent Mechanisms. Mol. Endocrinol. 21: 2270-2281 [Abstract] [Full Text]  
  • Diakonova, M., Helfer, E., Seveau, S., Swanson, J. A., Kocks, C., Rui, L., Carlier, M.-F., Carter-Su, C. (2007). Adapter Protein SH2-B{beta} Stimulates Actin-Based Motility of Listeria monocytogenes in a Vasodilator-Stimulated Phosphoprotein (VASP)-Dependent Fashion. Infect. Immun. 75: 3581-3593 [Abstract] [Full Text]  
  • Kurzer, J. H., Saharinen, P., Silvennoinen, O., Carter-Su, C. (2006). Binding of SH2-B Family Members within a Potential Negative Regulatory Region Maintains JAK2 in an Active State. Mol. Cell. Biol. 26: 6381-6394 [Abstract] [Full Text]  
  • Li, M., Ren, D., Iseki, M., Takaki, S., Rui, L. (2006). Differential Role of SH2-B and APS in Regulating Energy and Glucose Homeostasis. Endocrinology 147: 2163-2170 [Abstract] [Full Text]  
  • Miquet, J G, Sotelo, A I, Dominici, F P, Bonkowski, M S, Bartke, A, Turyn, D (2005). Increased sensitivity to GH in liver of Ames dwarf (Prop1df/Prop1df) mice related to diminished CIS abundance. J Endocrinol 187: 387-397 [Abstract] [Full Text]  
  • Miquet, J. G., Sotelo, A. I., Bartke, A., Turyn, D. (2005). Desensitization of the JAK2/STAT5 GH signaling pathway associated with increased CIS protein content in liver of pregnant mice. Am. J. Physiol. Endocrinol. Metab. 289: E600-E607 [Abstract] [Full Text]  
  • Miquet, J G, Sotelo, A I, Bartke, A, Turyn, D (2005). Increased SH2-B{beta} content and membrane association in transgenic mice overexpressing GH. J Endocrinol 185: 301-306 [Abstract] [Full Text]  
  • Nishi, M., Werner, E. D., Oh, B.-C., Frantz, J. D., Dhe-Paganon, S., Hansen, L., Lee, J., Shoelson, S. E. (2005). Kinase Activation through Dimerization by Human SH2-B. Mol. Cell. Biol. 25: 2607-2621 [Abstract] [Full Text]  
  • Dunn, S. L., Bjornholm, M., Bates, S. H., Chen, Z., Seifert, M., Myers, M. G. Jr. (2005). Feedback Inhibition of Leptin Receptor/Jak2 Signaling via Tyr1138 of the Leptin Receptor and Suppressor of Cytokine Signaling 3. Mol. Endocrinol. 19: 925-938 [Abstract] [Full Text]  
  • Duan, C., Li, M., Rui, L. (2004). SH2-B Promotes Insulin Receptor Substrate 1 (IRS1)- and IRS2-mediated Activation of the Phosphatidylinositol 3-Kinase Pathway in Response to Leptin. J. Biol. Chem. 279: 43684-43691 [Abstract] [Full Text]  
  • Leung, K.-C., Johannsson, G., Leong, G. M., Ho, K. K. Y. (2004). Estrogen Regulation of Growth Hormone Action. Endocr. Rev. 25: 693-721 [Abstract] [Full Text]  
  • Ling, L., Lobie, P. E. (2004). RhoA/ROCK Activation by Growth Hormone Abrogates p300/Histone Deacetylase 6 Repression of Stat5-mediated Transcription. J. Biol. Chem. 279: 32737-32750 [Abstract] [Full Text]  
  • Kurzer, J. H., Argetsinger, L. S., Zhou, Y.-J., Kouadio, J.-L. K., O'Shea, J. J., Carter-Su, C. (2004). Tyrosine 813 Is a Site of JAK2 Autophosphorylation Critical for Activation of JAK2 by SH2-B{beta}. Mol. Cell. Biol. 24: 4557-4570 [Abstract] [Full Text]  
  • Chen, L., Carter-Su, C. (2004). Adapter Protein SH2-B{beta} Undergoes Nucleocytoplasmic Shuttling: Implications for Nerve Growth Factor Induction of Neuronal Differentiation. Mol. Cell. Biol. 24: 3633-3647 [Abstract] [Full Text]  
  • Ling, L., Zhu, T., Lobie, P. E. (2003). Src-CrkII-C3G-dependent Activation of Rap1 Switches Growth Hormone-stimulated p44/42 MAP Kinase and JNK/SAPK Activities. J. Biol. Chem. 278: 27301-27311 [Abstract] [Full Text]  
  • O'Brien, K. B., Argetsinger, L. S., Diakonova, M., Carter-Su, C. (2003). YXXL Motifs in SH2-Bbeta Are Phosphorylated by JAK2, JAK1, and Platelet-derived Growth Factor Receptor and Are Required for Membrane Ruffling. J. Biol. Chem. 278: 11970-11978 [Abstract] [Full Text]  
  • Carpino, N., Kobayashi, R., Zang, H., Takahashi, Y., Jou, S.-T., Feng, J., Nakajima, H., Ihle, J. N. (2002). Identification, cDNA Cloning, and Targeted Deletion of p70, a Novel, Ubiquitously Expressed SH3 Domain-Containing Protein. Mol. Cell. Biol. 22: 7491-7500 [Abstract] [Full Text]  
  • Kong, M., Wang, C. S., Donoghue, D. J. (2002). Interaction of Fibroblast Growth Factor Receptor 3 and the Adapter Protein SH2-B. A ROLE IN STAT5 ACTIVATION. J. Biol. Chem. 277: 15962-15970 [Abstract] [Full Text]  
  • Ohtsuka, S., Takaki, S., Iseki, M., Miyoshi, K., Nakagata, N., Kataoka, Y., Yoshida, N., Takatsu, K., Yoshimura, A. (2002). SH2-B Is Required for Both Male and Female Reproduction. Mol. Cell. Biol. 22: 3066-3077 [Abstract] [Full Text]  
  • Diakonova, M., Gunter, D. R., Herrington, J., Carter-Su, C. (2002). SH2-Bbeta Is a Rac-binding Protein That Regulates Cell Motility. J. Biol. Chem. 277: 10669-10677 [Abstract] [Full Text]  
  • O'Brien, K. B., O'Shea, J. J., Carter-Su, C. (2002). SH2-B Family Members Differentially Regulate JAK Family Tyrosine Kinases. J. Biol. Chem. 277: 8673-8681 [Abstract] [Full Text]  
  • Yousaf, N., Deng, Y., Kang, Y., Riedel, H. (2001). Four PSM/SH2-B Alternative Splice Variants and Their Differential Roles in Mitogenesis. J. Biol. Chem. 276: 40940-40948 [Abstract] [Full Text]